Autopsy report · NCT00751933

Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis

“Lack of patients compatible with the protocol´s criteria”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 8 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 4 years 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Haukeland University Hospital

Sponsor type

University, hospital or other

Conditions

Ulcerative Colitis

Interventions

Vaccine Vivotif + Vaccine Dukoral + oats; Vaccine Vivotif + Vaccine Dukoral; Oats; Placebo

Participants

3

Sites

1

Countries

Norway

Trials that died the same way

• Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)
  “No patient completed protocol” (70% match in meaning)
• Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy
  “Failure to include patients” (68% match in meaning)
• Effect of Paricalcitol Over Vessel Wall
  “Protocol showed to be inappropriate for the evaluation of the selected patients” (68% match in meaning)
• A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma
  “Suitable patients were not recruited” (68% match in meaning)
• Endothelial Protection in Convalescent COVID-19 Patients
  “Lack of the eligible patients” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.